Fresenius Group Overview

March 30, 2020

Fresenius postpones 2020 Annual General Meeting

  • New date will be specified and communicated as soon as reliable planning is possible
  • Health and safety of shareholders and employees is our priority

Due to the coronavirus pandemic, Fresenius SE & Co. KGaA postpones its Annual General Meeting scheduled for 20 May 2020 to a later date within the current financial year. As one of the consequences, this will lead to a postponement of the resolutions regarding the appropriation of net income 2019 and the payout of the dividend. The Company will set and communicate a new date as soon as the conditions for reliable planning and safe execution of the Annual General Meeting are once again in place.

“At present, the primary task is to slow down the spread of the coronavirus and thus to contain it as far as possible. With this decision, we are also supporting this common goal. The health and safety of our shareholders and employees have highest priority,” said Stephan Sturm, CEO of Fresenius.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.